Ghoncheh M, Pournamdar Z, Salehiniya H. Incidence and Mortality and Epidemiology of Breast Cancer in the World. Asian Pac J Cancer Prev. 2016;17:43–6. https://doi.org/10.7314/APJCP.2016.17.S3.43.
Giaquinto AN, Sung H, Miller KD, Kramer JL, Newman LA, Minihan A, et al. Breast Cancer Statistics, 2022. CA Cancer J Clin. 2022;72:524–41. https://doi.org/10.3322/caac.21754.
Bottomley A, Reijneveld JC, Koller M, Flechtner H, Tomaszewski KA, Greimel E, et al. Current state of quality of life and patient-reported outcomes research. Eur J Cancer. 2019;121:55–63. https://doi.org/10.1016/j.ejca.2019.08.016.
Denieffe S, Gooney M. A meta-synthesis of women’s symptoms experience and breast cancer. Eur J Cancer Care (Engl). 2011;20:424–35. https://doi.org/10.1111/j.1365-2354.2010.01223.x.
Article CAS PubMed Google Scholar
Javan Biparva A, Raoofi S, Rafiei S, Pashazadeh Kan F, Kazerooni M, Bagheribayati F, et al. Global quality of life in breast cancer: systematic review and meta-analysis. BMJ Support Palliat Care. 2022;13:e528–36. https://doi.org/10.1136/bmjspcare-2022-003642.
Article PubMed Central Google Scholar
Heins MJ, de Ligt KM, Verloop J, Siesling S, Korevaar JC, PSCCR group. Adverse health effects after breast cancer up to 14 years after diagnosis. Breast. 2022;61:22–8. https://doi.org/10.1016/j.breast.2021.12.001.
Dominick KL, Ahern FM, Gold CH, Heller DA. Relationship of health-related quality of life to health care utilization and mortality among older adults. Aging Clin Exp Res. 2002;14:499–508. https://doi.org/10.1007/BF03327351.
Warrington L, Absolom K, Conner M, Kellar I, Clayton B, Ayres M, et al. Electronic Systems for Patients to Report and Manage Side Effects of Cancer Treatment: Systematic Review. J Med Internet Res. 2019;21:e10875. https://doi.org/10.2196/10875.
Article PubMed PubMed Central Google Scholar
Lizán L, Pérez-Carbonell L, Comellas M. Additional value of patient-reported symptom monitoring in cancer care: a systematic review of the literature. Cancers (Basel). 2021;13:4615. https://doi.org/10.3390/cancers13184615.
Article PubMed PubMed Central Google Scholar
Consolo L, Castellini G, Cilluffo S, Basile I, Lusignani M. Electronic patient-reported outcomes (e-PROMs) in palliative cancer care: a scoping review. J Patient-Reported Outcomes. 2022;6:102.
Basch E, Schrag D, Henson S, Jansen J, Ginos B, Stover AM, et al. Effect of electronic symptom monitoring on patient-reported outcomes among patients with metastatic cancer: a randomized clinical trial. JAMA. 2022;327:2413–22.
Article PubMed PubMed Central Google Scholar
van den Hurk CJG, Mols F, Eicher M, Chan RJ, Becker A, Geleijnse G, et al. A narrative review on the collection and use of electronic patient-reported outcomes in cancer survivorship care with emphasis on symptom monitoring. Curr Oncol. 2022;29:4370–85.
Article PubMed PubMed Central Google Scholar
Maguire R, McCann L, Kotronoulas G, Kearney N, Ream E, Armes J, et al. Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART). BMJ. 2021; n1647. https://doi.org/10.1136/bmj.n1647
Howell D, Li M, Sutradhar R, Gu S, Iqbal J, O’Brien MA, et al. Integration of patient-reported outcomes (PROs) for personalized symptom management in “real-world” oncology practices: a population-based cohort comparison study of impact on healthcare utilization. Support Care Cancer. 2020;28:4933–42.
Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P, et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol. 2016;34:557–65.
Article CAS PubMed Google Scholar
Denis F, Lethrosne C, Pourel N, Molinier O, Pointreau Y, Domont J, et al. Randomized Trial Comparing a Web-Mediated Follow-up With Routine Surveillance in Lung Cancer Patients. J Natl Cancer Inst. 2017; 109. [Internet], Available from: http://www.ncbi.nlm.nih.gov/pubmed/28423407
Basch E, Stover AM, Schrag D, Chung A, Jansen J, Henson S, et al. Clinical utility and user perceptions of a digital system for electronic patient-reported symptom monitoring during routine cancer care: findings from the PRO-TECT trial. JCO Clin cancer informatics. 2020;4:947–57.
Lee M, Kang D, Kang E, Kim S, Kim Y, Ahn JS, et al. Efficacy of the PRO-CTCAE mobile application for improving patient participation in symptom management during cancer treatment: a randomized controlled trial. Support Care Cancer. 2023;31:321. https://doi.org/10.1007/s00520-023-07779-3.
Article PubMed PubMed Central Google Scholar
Billingy NE, Tromp VNMF, Aaronson NK, Hoek RJA, Bogaard HJ, Onwuteaka-Philipsen BD, et al. Quality of life after patient-initiated vs physician-initiated response to symptom monitoring: the SYMPRO-Lung trial. JNCI J Natl Cancer Inst. 2023;15:1515–25. https://doi.org/10.1093/jnci/djad159/7246746.
van Eenbergen MC, van den Hurk C, Mols F, van de Poll-Franse LV. Usability of an online application for reporting the burden of side effects in cancer patients. Support Care Cancer. 2019;27:3411–9. https://doi.org/10.1007/s00520-019-4639-1.
Graupner C, Kimman ML, Mul S, Slok AHM, Claessens D, Kleijnen J, et al. Patient outcomes, patient experiences and process indicators associated with the routine use of patient-reported outcome measures (PROMs) in cancer care: a systematic review. Support Care Cancer. 2021;29:573–93. https://doi.org/10.1007/s00520-020-05695-4.
Finucane AM, O’Donnell H, Lugton J, Gibson-Watt T, Swenson C, Pagliari C. Digital health interventions in palliative care: a systematic meta-review. npj Digit Med. 2021;4:64.
Article PubMed PubMed Central Google Scholar
Henry DH, Viswanathan HN, Elkin EP, Traina S, Wade S, Cella D. Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the U.S. Support Care Cancer. 2008;16:791–801.
Koo MM, von Wagner C, Abel GA, McPhail S, Rubin GP, Lyratzopoulos G. Typical and atypical presenting symptoms of breast cancer and their associations with diagnostic intervals: Evidence from a national audit of cancer diagnosis. Cancer Epidemiol. 2017;48:140–6.
Article PubMed PubMed Central Google Scholar
Federatie Medisch Specialisten. borstkanker richtlijnen. 2022; Available from: https://richtlijnendatabase.nl/richtlijn/borstkanker/algemeen.html. Accessed 25 Oct 2022
Solvi AS, Foss K, von Soest T, Roald HE, Skolleborg KC, Holte A. Motivational factors and psychological processes in cosmetic breast augmentation surgery. J Plast Reconstr Aesthetic Surg. 2010;63:673–80.
Waks AG, Winer EP. Breast cancer treatment: a review. JAMA. 2019;321:288–300.
Article CAS PubMed Google Scholar
Clarijs ME, Thurell J, Kühn F, Uyl-de Groot CA, Hedayati E, Karsten MM, et al. Measuring quality of life using patient-reported outcomes in real-world metastatic breast cancer patients: the need for a standardized approach. Cancers (Basel). 2021;13:2308.
Article PubMed PubMed Central Google Scholar
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:71.
Higgins JPT, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928–d5928. https://doi.org/10.1136/bmj.d5928.
Article PubMed PubMed Central Google Scholar
Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available from: https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 29 Mar 2023
Öztürk ES, Kutlutürkan S. The effect of the mobile application-based symptom monitoring process on the symptom control and quality of life in breast cancer patients. Semin Oncol Nurs. 2021;37:151161.
Takada F, Okuyama H, Nakamura S, Fujita K. Application of personal health record in enhancing the quality of life in patients with breast cancer who received adjuvant hormonal therapy. Eur J Breast Heal. 2022;18:155–62.
Fjell M, Langius-Eklöf A, Nilsson M, Wengström Y, Sundberg K. Reduced symptom burden with the support of an interactive app during neoadjuvant chemotherapy for breast cancer – A randomized controlled trial. The Breast. 2020;51:85–93.
Article PubMed PubMed Central Google Scholar
Grašič Kuhar C, Gortnar Cepeda T, Kovač T, Kukar M, Ružić Gorenjec N. Mobile app for symptom management and associated quality of life during system
Comments (0)